Clinical Trial Update: Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) program addressing hypertension; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Hypertension | Phase 3 | Status: UNKNOWN